Literature DB >> 15277672

Infecting the brain to stop addiction?

David Nutt1, Anne Lingford-Hughes.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15277672      PMCID： PMC509181          DOI： 10.1073/pnas.0404338101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  7 in total

1.  Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166)

Authors:  M K Romach; P Glue; K Kampman; H L Kaplan; G R Somer; S Poole; L Clarke; V Coffin; J Cornish; C P O'Brien; E M Sellers
Journal:  Arch Gen Psychiatry       Date:  1999-12

2.  Cocaine vaccines: antibody protection against relapse in a rat model.

Authors:  M R Carrera; J A Ashley; B Zhou; P Wirsching; G F Koob; K D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

3.  Antibody-catalyzed degradation of cocaine.

Authors:  D W Landry; K Zhao; G X Yang; M Glickman; T M Georgiadis
Journal:  Science       Date:  1993-03-26       Impact factor: 47.728

4.  Filamentous phage as vector-mediated antibody delivery to the brain.

Authors:  Dan Frenkel; Beka Solomon
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

5.  Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels.

Authors:  John Foster; Colin Brewer; Terry Steele
Journal:  Addict Biol       Date:  2003-06       Impact factor: 4.280

6.  Treating cocaine addiction with viruses.

Authors:  M Rocio A Carrera; Gunnar F Kaufmann; Jenny M Mee; Michael M Meijler; George F Koob; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-28       Impact factor: 11.205

7.  GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine.

Authors:  R B Rothman; A Mele; A A Reid; H C Akunne; N Greig; A Thurkauf; B R de Costa; K C Rice; A Pert
Journal:  Pharmacol Biochem Behav       Date:  1991-10       Impact factor: 3.533
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.